UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2013-06, Vol.16 (2), p.187-192

2013

Volltextzugriff (PDF)

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

ESMO open, 2023-12, Vol.8 (6), p.102065-102065, Article 102065

2023

Volltextzugriff (PDF)

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients

ESMO open, 2022-02, Vol.7 (1), p.100394-100394, Article 100394

2022

Volltextzugriff (PDF)

The management of the shoulder skin microbiome (Cutibacterium acnes) in the context of shoulder surgery: a review of the current literature

Shoulder & elbow, 2021-10, Vol.13 (6), p.592-599

2021

Volltextzugriff (PDF)

Paclitaxel and tamoxifen : An active regimen for patients with metastatic melanoma

Cancer, 2000, Vol.88 (1), p.79-87

2000

Volltextzugriff (PDF)

THE MALE SLING FOR STRESS URINARY INCONTINENCE: URODYNAMIC AND SUBJECTIVE ASSESSMENT

The Journal of urology, 2004-07, Vol.172 (1), p.204-206

2004

Volltextzugriff (PDF)

Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer

Seminars in oncology, 1995-10, Vol.22 (5), p.41-45

1995

Volltextzugriff (PDF)

THE MALE SLING FOR STRESS URINARY INCONTINENCE: 24-MONTH FOLLOWUP WITH QUESTIONNAIRE BASED ASSESSMENT

The Journal of urology, 2004-07, Vol.172 (1), p.207-209

2004

Volltextzugriff (PDF)

Antiandrogen Withdrawal Syndrome With Nilutamide

The Journal of urology, 1997-04, Vol.157 (4), p.1366-1366

1997

Volltextzugriff (PDF)

Active specific immunization in the treatment of patients with melanoma: Melanoma

Seminars in oncology, 1996-12, Vol.23 (6), p.773-781

1996

Volltextzugriff (PDF)

Protracted survival after resection of metastatic uveal melanoma

Cancer, 2000-10, Vol.89 (7), p.1561-1568

2000

Volltextzugriff (PDF)

Universal aspects of cohesion

Granular matter, 2022-02, Vol.24 (1), Article 35

2022

Volltextzugriff (PDF)

BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy

Journal of experimental & clinical cancer research, 1997-06, Vol.16 (2), p.201

1997

Volltextzugriff (PDF)

A TECHNIQUE OF BLADDER NECK CLOSURE COMBINING PROSTATECTOMY AND INTESTINAL INTERPOSITION FOR UNSALVAGEABLE URETHRAL DISEASE

The Journal of urology, 2002-02, Vol.167 (2), p.634-636

2002

Volltextzugriff (PDF)

Gene therapy for human cancer: an essay for clinicians

Seminars in oncology, 1996-02, Vol.23 (1), p.4-21

1996

Volltextzugriff (PDF)

Adjuvant therapy for cutaneous melanoma

Seminars in oncology, 1995-12, Vol.22 (6), p.647-661

1995

Volltextzugriff (PDF)

Plasma thrombospondin levels in patients with gynecologic malignancies

Cancer, 1994-06, Vol.73 (11), p.2853-2858

1994

Volltextzugriff (PDF)

LBA4_PRNivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Metatarsal fracture management

Orthopaedics and trauma, 2018-12, Vol.32 (6), p.428-436

Moore, Nathan FE

2018

Volltextzugriff (PDF)

Detection of metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4655-4655

2011

Volltextzugriff (PDF)

Role of detection of metastatic disease as a leading cause of screening failure in an ongoing phase III trial of zibotentan versus placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.135-135

2011

Volltextzugriff (PDF)

Treatment patterns by oncologists and urologists for castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.6083-6083

2010

Volltextzugriff (PDF)

Lung cancer. Part 1. Introduction

Seminars in oncology, 1993-04, Vol.20 (2), p.103-104

Nathan, F E

1993

Volltextzugriff (PDF)

Routledge Handbook of Nuclear Proliferation and Policy

1, 2015

Volltextzugriff (PDF)

Anti-Baka Neonatal Alloimmune Thrombocytopenia: Possible Prevention by Intravenous Immunoglobulin

Pediatric hematology and oncology, 1994-01, Vol.11 (3), p.325-329

1994

Volltextzugriff (PDF)

1 – 25 von 3.977

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.552)
Mit Volltextzugriff
(3.248)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.781)
Life Sciences & Biomedicine
(2.184)
Humans
(1.617)
Male
(919)
Female
(914)
Biological And Medical Sciences
(559)
Adult
(530)
Middle Aged
(522)
Animals
(454)
Medical Sciences
(439)
Aged
(404)
Physical Sciences
(387)
Science & Technology - Other Topics
(242)
Adolescent
(223)
Multidisciplinary Sciences
(218)
Neurosciences & Neurology
(212)
Technology
(210)
General & Internal Medicine
(207)
Risk Factors
(207)
Biochemistry & Molecular Biology
(197)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients

The management of the shoulder skin microbiome (Cutibacterium acnes) in the context of shoulder surgery: a review of the current literature

Paclitaxel and tamoxifen : An active regimen for patients with metastatic melanoma

THE MALE SLING FOR STRESS URINARY INCONTINENCE: URODYNAMIC AND SUBJECTIVE ASSESSMENT

Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer

THE MALE SLING FOR STRESS URINARY INCONTINENCE: 24-MONTH FOLLOWUP WITH QUESTIONNAIRE BASED ASSESSMENT

Antiandrogen Withdrawal Syndrome With Nilutamide

Active specific immunization in the treatment of patients with melanoma: Melanoma

Protracted survival after resection of metastatic uveal melanoma

Universal aspects of cohesion

BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy

A TECHNIQUE OF BLADDER NECK CLOSURE COMBINING PROSTATECTOMY AND INTESTINAL INTERPOSITION FOR UNSALVAGEABLE URETHRAL DISEASE

Gene therapy for human cancer: an essay for clinicians

Adjuvant therapy for cutaneous melanoma

Plasma thrombospondin levels in patients with gynecologic malignancies

LBA4_PRNivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis

Metatarsal fracture management

Detection of metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)

Role of detection of metastatic disease as a leading cause of screening failure in an ongoing phase III trial of zibotentan versus placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)

Treatment patterns by oncologists and urologists for castration-resistant prostate cancer (CRPC)

Lung cancer. Part 1. Introduction

Routledge Handbook of Nuclear Proliferation and Policy

Anti-Baka Neonatal Alloimmune Thrombocytopenia: Possible Prevention by Intravenous Immunoglobulin

Suchergebnisse filtern